A trial comparing the pharmaceutical equivalence of sumatriptan transdermal patches used in a phase III pivotal trial with patches prepared for commercial use in adult volunteers.

Trial Profile

A trial comparing the pharmaceutical equivalence of sumatriptan transdermal patches used in a phase III pivotal trial with patches prepared for commercial use in adult volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 10 Jun 2011

At a glance

  • Drugs Sumatriptan (Primary)
  • Indications Migraine
  • Focus Pharmacokinetics; Therapeutic Use
  • Sponsors NuPathe
  • Most Recent Events

    • 10 Jun 2011 New trial record
    • 05 Jun 2011 Results presented at the 53rd Annual Scientific Meeting of the American Headache Society.
    • 02 Jun 2011 Results will be presented at the 53rd Annual Scientific Meeting of the American Headache Society according to a NuPathe media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top